Lancet

Skip to Main Content

Showing: 1-20

Articles

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Sarah A Holstein, Sin-Ho Jung, Paul G Richardson, Craig C Hofmeister, David D Hurd, Hani Hassoun, Sergio Giralt, Edward A Stadtmauer, Daniel J Weisdorf, Ravi Vij, Jan S Moreb, Natalie S Callander, Koen van Besien, Teresa G Gentile, Luis Isola, Richard T Maziarz, Asad Bashey, Heather Landau, Thomas Martin, Muzaffar H Qazilbash, Cesar Rodriguez, Brian McClune, Robert L Schlossman, Scott E Smith, Vera Hars, Kouros Owzar, Chen Jiang, Molly Boyd, Chelsea Schultz, Marcia Wilson, Parameswaran Hari, Marcelo C Pasquini, Mary M Horowitz, Thomas C Shea, Steven M Devine, Charles Linker, Kenneth C Anderson, Philip L McCarthy

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30140-0

The Lancet Haematology

Published: August 17, 2017

Full-Text HTML PDF

Clinical Picture

Tumour d'emblee

Online Only

Razmi T Muhammed, Sanjeev Handa, Rahul Mahajan, Uma Nahar Saikia, Bhagwant Rai Mittal

DOI: http://dx.doi.org/10.1016/S1470-2045(17)30333-9

The Lancet Oncology, Vol. 18, No. 8

Published: August, 2017

Full-Text HTML PDF

Articles

EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis

Thomas Luft, Axel Benner, Sonata Jodele, Christopher E Dandoy, Rainer Storb, Ted Gooley, Brenda M Sandmaier, Natalia Becker, Aleksandar Radujkovic, Peter Dreger, Olaf Penack

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30108-4

The Lancet Haematology

Published: July 18, 2017

Full-Text HTML PDF

Articles

Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study

Online Only

Wojciech Jurczak, Ilídia Moreira, Govind Babu Kanakasetty, Eduardo Munhoz, Maria Asunción Echeveste, Pratyush Giri, Nelson Castro, Juliana Pereira, Luiza Akria, Sergey Alexeev, Eugeniy Osmanov, Peijuan Zhu, Siyka Alexandrova, Angela Zubel, Olof Harlin, Jutta Amersdorffer

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30106-0

The Lancet Haematology, Vol. 4, No. 8

Published: July 13, 2017

Full-Text HTML PDF

Articles

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

Online Only

Won Seog Kim, Christian Buske, Michinori Ogura, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajinish Nagarkar, Dzhelil Osmanov, Larry W Kwak, Sang Joon Lee, Sung Young Lee, Yun Ju Bae, Bertrand Coiffier

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30120-5

The Lancet Haematology, Vol. 4, No. 8

Published: July 13, 2017

Full-Text HTML PDF

Articles

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

Online Only

Hagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, Matthias Stelljes, Partow Kebriaei, Ryan D Cassaday, Akil A Merchant, Naohito Fujishima, Toshiki Uchida, Maria Calbacho, Anna A Ejduk, Susan M O'Brien, Elias J Jabbour, Hui Zhang, Barbara J Sleight, Erik R Vandendries, David I Marks

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30103-5

The Lancet Haematology, Vol. 4, No. 8

Published: July 4, 2017

Full-Text HTML PDF

Articles

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Online Only

Claire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, Jean-Jacques Kiladjian, Ramon V Tiu, Pierre Zachee, Eric Jourdan, Elliott Winton, Richard T Silver, Harry C Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Joanne Lager, Zhenming Shun, Ruben A Mesa

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30088-1

The Lancet Haematology, Vol. 4, No. 7

Published: June 8, 2017

Full-Text HTML PDF

Articles

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial

Online Only

Richard E Clark, Fotios Polydoros, Jane F Apperley, Dragana Milojkovic, Christopher Pocock, Graeme Smith, Jenny L Byrne, Hugues de Lavallade, Stephen G O'Brien, Tony Coffey, Letizia Foroni, Mhairi Copland

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30066-2

The Lancet Haematology, Vol. 4, No. 7

Published: May 26, 2017

Full-Text HTML PDF

Articles

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan

Online Only

Yago Nieto, Benigno C Valdez, Sai R Pingali, Roland Bassett, Ruby Delgado, John Nguyen, Nina Shah, Uday Popat, Roy B Jones, Borje S Andersson, Alison Gulbis, Sairah Ahmed, Qaiser Bashir, Simrit Parmar, Krina Patel, Alan Myers, Gabriela Rondon, Robert Z Orlowski, Richard Champlin, Muzaffar Qazilbash

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30080-7

The Lancet Haematology, Vol. 4, No. 6

Published: May 15, 2017

Full-Text HTML PDF

Articles

Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial

Online Only

Andrew Davies, Francesco Merli, Biljana Mihaljević, Santiago Mercadal, Noppadol Siritanaratkul, Philippe Solal-Céligny, Axel Boehnke, Claude Berge, Magali Genevray, Artem Zharkov, Mark Dixon, Michael Brewster, Martin Barrett, David MacDonald

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30078-9

The Lancet Haematology, Vol. 4, No. 6

Published: May 2, 2017

Full-Text HTML PDF

Articles

Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

Online Only

Audrey Bonaventure, Rhea Harewood, Charles A Stiller, Gemma Gatta, Jacqueline Clavel, Daniela C Stefan, Helena Carreira, Devon Spika, Rafael Marcos-Gragera, Rafael Peris-Bonet, Marion Piñeros, Milena Sant, Claudia E Kuehni, Michael F G Murphy, Michel P Coleman, Claudia Allemani the CONCORD Working Group

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30052-2

The Lancet Haematology, Vol. 4, No. 5

Published: April 11, 2017

Open Access

Full-Text HTML PDF

Clinical Picture

AIDS-related primary CNS lymphoma

Sumit J Karia, David J T McArdle

DOI: http://dx.doi.org/10.1016/S0140-6736(17)30056-9

The Lancet, Vol. 389, No. 10085

Published: April 6, 2017

Full-Text HTML PDF

Articles

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Online Only

Ruben A Mesa, Alessandro M Vannucchi, Adam Mead, Miklos Egyed, Anita Szoke, Aleksandr Suvorov, Janos Jakucs, Andrew Perkins, Ritam Prasad, Jiri Mayer, Judit Demeter, Peter Ganly, Jack W Singer, Huafeng Zhou, James P Dean, Peter A te Boekhorst, Jyoti Nangalia, Jean-Jacques Kiladjian, Claire N Harrison

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30027-3

The Lancet Haematology, Vol. 4, No. 5

Published: March 20, 2017

Full-Text HTML PDF

Articles

Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial

Online Only

Lucia Masarova, Keyur P Patel, Kate J Newberry, Jorge Cortes, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop Kantarjian, Srdan Verstovsek

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30030-3

The Lancet Haematology, Vol. 4, No. 4

Published: March 10, 2017

Full-Text HTML PDF

Articles

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

Stine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, Jonas Abrahamsson, Bendik Lund, Jukka Kanerva, Ólafur Gísli Jónsson, Goda Vaitkeviciene, Kaie Pruunsild, Lisa Lyngsie Hjalgrim, Kjeld Schmiegelow

DOI: http://dx.doi.org/10.1016/S1470-2045(17)30154-7

The Lancet Oncology, Vol. 18, No. 4

Published: February 28, 2017

Full-Text HTML PDF

Articles

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Online Only

Andrés J M Ferreri, Marianna Sassone, Francesco Zaja, Alessandro Re, Michele Spina, Alice Di Rocco, Alberto Fabbri, Caterina Stelitano, Maurizio Frezzato, Chiara Rusconi, Renato Zambello, Suzana Couto, Yan Ren, Annalisa Arcari, Giovanni Bertoldero, Alessandro Nonis, Lydia Scarfò, Teresa Calimeri, Caterina Cecchetti, Marianna Chiozzotto, Silvia Govi, Maurilio Ponzoni

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30016-9

The Lancet Haematology, Vol. 4, No. 3

Published: February 16, 2017

Full-Text HTML PDF

Articles

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Online Only

Esther N Oliva, Caterina Alati, Valeria Santini, Antonella Poloni, Alfredo Molteni, Pasquale Niscola, Flavia Salvi, Grazia Sanpaolo, Enrico Balleari, Ulrich Germing, Pierre Fenaux, Aspasia Stamatoullas, Giuseppe A Palumbo, Prassede Salutari, Stefana Impera, Paolo Avanzini, Agostino Cortelezzi, Anna Marina Liberati, Paola Carluccio, Francesco Buccisano, Maria Teresa Voso, Stefano Mancini, Austin Kulasekararaj, Fortunato Morabito, Monica Bocchia, Patrizia Cufari, Maria Antonietta Aloe Spiriti, Irene Santacaterina, Maria Grazia D'Errigo, Irene Bova, Gina Zini, Roberto Latagliata

DOI: http://dx.doi.org/10.1016/S2352-3026(17)30012-1

The Lancet Haematology, Vol. 4, No. 3

Published: February 2, 2017

Full-Text HTML PDF

Articles

Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial

Online Only

Preetesh Jain, Michael Keating, Sarah Renner, Charles Cleeland, Huang Xuelin, Graciela Nogueras Gonzalez, David Harris, Ping Li, Zhiming Liu, Ivo Veletic, Uri Rozovski, Nitin Jain, Phillip Thompson, Prithviraj Bose, Courtney DiNardo, Alessandra Ferrajoli, Susan O'Brien, Jan Burger, William Wierda, Srdan Verstovsek, Hagop Kantarjian, Zeev Estrov

DOI: http://dx.doi.org/10.1016/S2352-3026(16)30194-6

The Lancet Haematology, Vol. 4, No. 2

Published: January 11, 2017

Full-Text HTML PDF

Articles

Consolidation anti-CD22 fractionated radioimmunotherapy with ⁹⁰Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial

Online Only

Françoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, Loïc Campion, Anne Moreau, Isabelle Soubeyran, Steven Le Gouill, Olivier Tournilhac, Etienne Daguindau, Henry Jardel, Nadine Morineau, Krimo Bouabdallah, Emmanuel Gyan, Marie-Pierre Moles, Remy Gressin, Christian Berthou, Sophie Sadot, Philippe Moreau, Bénédicte Deau, Caroline Bodet-Milin, Anne-Laure Cazeau, Etienne Garin, Pierre-Yves Salaun, Jean-Philippe Vuillez, Valérie Gouilleux-Gruart, Jacques Barbet, William A Wegener, David M Goldenberg, Thierry Lamy, Pierre Soubeyran

DOI: http://dx.doi.org/10.1016/S2352-3026(16)30168-5

The Lancet Haematology, Vol. 4, No. 1

Published: December 7, 2016

Full-Text HTML PDF

Articles

Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial

Online Only

Jorge E Cortes, Carmino Antonio De Souza, Manuel Ayala, Jose Luis Lopez, Eduardo Bullorsky, Sandip Shah, Xiaojun Huang, K Govind Babu, Kudrat Abdulkadyrov, José Salvador Rodrigues de Oliveira, Zhi-Xiang Shen, Tomasz Sacha, Israel Bendit, Zhizhou Liang, Tina Owugah, Tomasz Szczudlo, Sadhvi Khanna, Rafik Fellague-Chebra, Philipp D le Coutre

DOI: http://dx.doi.org/10.1016/S2352-3026(16)30167-3

The Lancet Haematology, Vol. 3, No. 12

Published: December, 2016

Full-Text HTML PDF

Copyright © 2017 Elsevier Limited except certain content provided by third parties.

The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.

The Lancet.com website is operated by Elsevier Inc. The content on this site is intended for health professionals.

Cookies are set by this site. To decline them or learn more, visit our Cookies page.

The Lancet demonstrates its commitment to accessibility by enabling access and optimising the experience for individuals with disabilities and impairments.